beyfortus sanofi news - Search News

Sanofi, BEYFORTUS

GlobalData on MSN · 2d

Sanofi begins shipping BEYFORTUS to US for RSV prevention in infants

French multinational pharmaceutical company Sanofi has commenced the shipping of BEYFORTUS (nirsevimab-alip) to the US, targeting both private healthcare providers and the Centers for Disease Control and Prevention's Vaccines for Children programme,

The Pharma Letter · 2d

Sanofi shipping RSV jab Beyfortus in USA

French pharma major Sanofi today revealed it is shipping Beyfortus (nirsevimab-alip) 50mg and 100mg Injection doses in the USA to private healthcare providers and to the Centers for Disease Control and Prevention.

Business Insider · 3d

Sanofi To Offer BEYFORTUS Doses To Protect Babies During RSV Season - Quick Facts

Sanofi (SNYNF, SNY) said it is shipping BEYFORTUS 50mg and 100mg Injection doses in the US to private healthcare providers and to the

Reuters on MSN · 3d

Sanofi, AstraZeneca win approval for RSV therapy manufacturing line

Sanofi and partner AstraZeneca have received approval from the U.S. Food and Drug Administration for a manufacturing line for their preventive respiratory

Sanofi Shipping BEYFORTUS® In US To Help Protect Babies Against RSV Disease New Manufacturing Line Approved By FDA

Company planning for every eligible baby in the US to have access to BEYFORTUS <li /> New BEYFORTUS filling line approved by the

With amped up manufacturing effort, Sanofi and AZ look to avoid Beyfortus shortfalls this year

As this year’s respiratory syncytial virus (RSV) season approaches, Beyfortus makers Sanofi and AstraZeneca are making ...

Zacks.com on MSN10h

Sanofi Stock Up Almost 23% in 3 Months: Buy, Sell or Hold?

Sanofi’s SNY stock has gained 22.7% in the past three months compared with an increase of 2.9% for the industry. The stock ...

ENDPOINTS NEWS13h

BioCentriq names ex-Resilient exec as new CEO; Sanofi, AstraZeneca boost Beyfortus production

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...

BioPharma Dive3d

Sanofi readies to meet US demand for RSV antibody

With a new production line, Sanofi aims to keep it and partner AstraZeneca’s drug Beyfortus in fully supply this RSV season.

18d

Sanofi MS drug tolebrutinib misses goal in relapsing disease trials

Sanofi's most advanced multiple sclerosis (MS) drug candidate has missed the main goal of two late-stage trials to treat ...

Health Crisis Updates: From Nipah Virus to Polio Vaccinations

This summary covers various health news: a Nipah virus death in Kerala, Gaza's polio vaccination coverage success, brain ...

6d

RSV shot will be offered widely in Ontario and Quebec, but not in Western provinces

But unlike influenza and COVID, there were at that time no Health Canada-approved immunization options for RSV, except for ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results